An anonymous director reports

M PHARMACEUTICAL TO REQUEST DTC ELIGIBILITY TO IMPROVE LIQUIDITY ON THE OTCQB

M Pharmaceutical Inc. will engage a participant of the Depository Trust Company (DTC) to request that the company's securities become eligible for depository services. DTC eligibility allows for a company's securities to be traded electronically between brokerage accounts in the United States.

Matthew Lehman, M Pharmaceutical's chief executive officer said: "DTC eligibility is a significant step toward improving the liquidity of our stock in the U.S. market. This will allow for electronic trading of M Pharma's securities via the OTCQB which, as of this time, is not possible."

We seek Safe Harbor.